Monte Rosa Therapeutics, Inc. Employee Count
The employee counts Monte Rosa Therapeutics, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 150; Filing 2026-03-17; Lease expense per employee $61,466.67.
- 2024-12-31: Employees (as filed) 134; Filing 2025-03-20; Lease expense per employee $78,022.39.
- 2023-12-31: Employees (as filed) 133; Filing 2024-03-14; Lease expense per employee $71,112.78.
- 2022-12-31: Employees (as filed) 123; Filing 2023-03-16; Lease expense per employee $71,723.58.
- Available history
- 2022-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 150 full-time | 2026-03-17 | $61,466.67 total lease cost |
| 2024-12-31 | 134 full-time | 2025-03-20 | $78,022.39 total lease cost |
| 2023-12-31 | 133 full-time | 2024-03-14 | $71,112.78 total lease cost |
| 2022-12-31 | 123 full-time | 2023-03-16 | $71,723.58 total lease cost |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |